Bank of America
COYA icon

Bank of America’s Coya Therapeutics COYA Stock Holding History

Bank of America’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,784
Closed -$231K – 5966
2025
Q4 		$231K Buy
39,784
+39,569
+18,404% +$241K ﹤0.01% 5271
2025
Q3 		$1.23K Buy
215
+73
+51% +$444 ﹤0.01% 7463
2025
Q2 		$816 Buy
142
+21
+17% +$122 ﹤0.01% 7573
2025
Q1 		$783 Buy
121
+6
+5% +$38 ﹤0.01% 7461
2024
Q4 		$659 Buy
115
+9
+8% +$61 ﹤0.01% 7361
2024
Q3 		$684 Sell
106
-1
-0.9% -$6 ﹤0.01% 7317
2024
Q2 		$648 Sell
107
-1,518
-93% -$12.2K ﹤0.01% 7304
2024
Q1 		$16.1K Buy
1,625
+1,615
+16,150% +$12.7K ﹤0.01% 6787
2023
Q4 		$74 Buy
+10
New +$55 ﹤0.01% 7445
2023
Q3 		– Sell
-46,052
Closed -$187K – 7786
2023
Q2 		$187K Buy
+46,052
New +$214K ﹤0.01% 5878

Other funds holding COYA

DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Bank of America's COYA Position: Q1 2026 in Review

Bank of America sold out of Coya Therapeutics (COYA) in Q1 2026, closing a stake of 39,784 shares — an estimated $231K sold.

Bank of America first reported a position in COYA in Q2 2023 and held it in 10 quarters. The position peaked at $231K in Q4 2025. 56 funds tracked by Wall St. Rank hold COYA as of Q1 2026.

  • Bank of America reported no remaining Coya Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 39,784 Coya Therapeutics shares in Q1 2026, an estimated $231K.
  • Bank of America first reported a position in Coya Therapeutics in Q2 2023 and held it in 10 quarters.
  • Bank of America's Coya Therapeutics position peaked at $231K in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Coya Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.